Danimer Scientific (DNMR) Stock Forecast, Price Target & Predictions
DNMR Stock Forecast
Danimer Scientific stock forecast is as follows: an average price target of $0.90 (represents a 127.85% upside from DNMR’s last price of $0.40) and a rating consensus of 'Hold', based on 3 wall street analysts offering a 1-year stock forecast.
DNMR Price Target
The average price target for Danimer Scientific (DNMR) is $0.90 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $1.00 to $0.80. This represents a potential 127.85% upside from DNMR's last price of $0.40.
DNMR Analyst Ratings
According to 3 Wall Street analysts, Danimer Scientific's rating consensus is 'Hold'. The analyst rating breakdown for DNMR stock is 0 'Strong Buy' (0.00%), 0 'Buy' (0.00%), 3 'Hold' (100.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Danimer Scientific Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 21, 2024 | Charles Neivert | Piper Sandler | $1.00 | $0.41 | 140.96% | 153.16% |
| May 22, 2024 | Laurence Alexander | Jefferies | $0.80 | $0.81 | -1.06% | 102.53% |
| Apr 08, 2024 | Charles Neivert | Piper Sandler | $1.25 | $1.05 | 19.05% | 216.46% |
The latest Danimer Scientific stock forecast, released on Aug 21, 2024 by Charles Neivert from Piper Sandler, set a price target of $1.00, which represents a 140.96% increase from the stock price at the time of the forecast ($0.41), and a 153.16% increase from DNMR last price ($0.40).
Danimer Scientific Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 1 | 3 |
| Avg Price Target | $1.00 | $1.00 | $1.02 |
| Last Closing Price | $0.40 | $0.40 | $0.40 |
| Upside/Downside | 153.16% | 153.16% | 158.23% |
In the current month, the average price target of Danimer Scientific stock is $1.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 153.16% increase as opposed to Danimer Scientific's last price of $0.40. This month's average price target is down 0.00% compared to last quarter, and down -1.96% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 21, 2024 | Piper Sandler | Neutral | Neutral | Hold |
| Aug 12, 2024 | Cowen & Co. | Buy | Hold | Downgrade |
| May 22, 2024 | Jefferies | - | Hold | Downgrade |
| May 20, 2024 | Piper Sandler | Neutral | Neutral | Hold |
| Apr 08, 2024 | Piper Sandler | - | Neutral | Downgrade |
| Apr 04, 2024 | Cowen & Co. | Buy | Buy | Hold |
Danimer Scientific's last stock rating was published by Piper Sandler on Aug 21, 2024. The company gave DNMR a "Neutral" rating, the same as its previous rate.
Danimer Scientific Financial Forecast
Danimer Scientific Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $10.95M | $10.95M | $12.87M | $11.93M | $15.32M | $10.45M | - | $14.74M | $17.73M | $13.37M | $14.47M | $13.18M |
| Avg Forecast | $39.86M | $35.79M | $31.72M | $27.64M | $27.75M | $24.42M | $20.09M | $14.91M | $12.76M | $8.58M | $8.98M | $10.73M | $11.57M | $14.74M | $13.90M | $14.39M | $16.43M | $12.47M | $15.36M | $21.40M | $17.69M | $14.56M | $11.80M | $12.00M |
| High Forecast | $40.00M | $35.91M | $31.83M | $27.74M | $27.85M | $24.51M | $20.16M | $14.96M | $12.80M | $8.61M | $9.01M | $10.77M | $11.61M | $14.79M | $13.95M | $14.45M | $16.49M | $12.51M | $16.32M | $21.56M | $17.82M | $14.67M | $11.89M | $12.09M |
| Low Forecast | $39.77M | $35.71M | $31.64M | $27.58M | $27.69M | $24.37M | $20.05M | $14.88M | $12.73M | $8.56M | $8.96M | $10.70M | $11.54M | $14.71M | $13.87M | $14.36M | $16.40M | $12.44M | $14.40M | $21.16M | $17.49M | $14.40M | $11.67M | $11.86M |
| # Analysts | - | - | - | - | - | - | - | - | - | 1 | - | 1 | 2 | 1 | 1 | 1 | - | - | - | - | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.95% | 0.74% | 0.93% | 0.83% | 0.93% | 0.84% | - | 0.69% | 1.00% | 0.92% | 1.23% | 1.10% |
Danimer Scientific's average Quarter revenue forecast for Mar 24 based on 1 analysts is $10.73M, with a low forecast of $10.70M, and a high forecast of $10.77M. DNMR's average Quarter revenue forecast represents a -1.97% decrease compared to the company's last Quarter revenue of $10.95M (Dec 23).
Danimer Scientific EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - | - | - | 1 | - | 1 | 2 | 1 | 1 | 1 | - | - | - | - | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-31.03M | $-31.24M | $-24.97M | $-23.39M | $-30.47M | $31.97M | - | $-31.50M | $-52.90M | $-31.74M | $-18.84M | $-9.09M |
| Avg Forecast | $-25.93M | $-23.28M | $-20.63M | $-17.98M | $-18.05M | $-15.89M | $-13.07M | $-9.70M | $-8.30M | $-5.58M | $-5.84M | $-31.36M | $-7.53M | $-9.59M | $-9.04M | $-28.51M | $-10.69M | $-105.27K | $-9.99M | $-25.92M | $-6.71M | $-95.70K | $-7.68M | $-48.54M |
| High Forecast | $-25.87M | $-23.23M | $-20.58M | $-17.94M | $-18.01M | $-15.85M | $-13.04M | $-9.68M | $-8.28M | $-5.57M | $-5.83M | $-25.09M | $-7.51M | $-9.57M | $-9.02M | $-22.81M | $-10.67M | $-84.22K | $-9.37M | $-20.73M | $-5.37M | $-76.56K | $-7.59M | $-38.83M |
| Low Forecast | $-26.02M | $-23.36M | $-20.70M | $-18.04M | $-18.12M | $-15.94M | $-13.12M | $-9.73M | $-8.33M | $-5.60M | $-5.86M | $-37.63M | $-7.55M | $-9.62M | $-9.07M | $-34.21M | $-10.73M | $-126.32K | $-10.62M | $-31.10M | $-8.05M | $-114.84K | $-7.73M | $-58.24M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 4.12% | 3.26% | 2.76% | 0.82% | 2.85% | -303.69% | - | 1.22% | 7.89% | 331.70% | 2.45% | 0.19% |
0 analysts predict DNMR's average Quarter EBITDA for Dec 22 to be $-10.69M, with a high of $-10.67M and a low of $-10.73M. This is -133.44% lower than Danimer Scientific's previous annual EBITDA (Sep 22) of $31.97M.
Danimer Scientific Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - | - | - | 1 | - | 1 | 2 | 1 | 1 | 1 | - | - | - | - | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-39.43M | $-40.16M | $-39.24M | $-36.64M | $-28.05M | $-94.88M | - | $-26.39M | $-12.45M | $7.83M | $39.25M | $-94.73M |
| Avg Forecast | $-7.40M | $-7.49M | $-7.64M | $-9.05M | $-11.17M | $-11.84M | $-13.98M | $-16.04M | $-19.46M | $-23.24M | $-26.69M | $-35.23M | $-39.12M | $-29.99M | $-31.74M | $-32.03M | $-23.88M | $4.73M | $-24.61M | $-29.12M | $-10.79M | $4.30M | $36.21M | $-49.77M |
| High Forecast | $-7.37M | $-7.47M | $-7.62M | $-9.02M | $-11.14M | $-11.80M | $-13.93M | $-15.99M | $-19.40M | $-22.08M | $-26.61M | $-28.18M | $-37.11M | $-29.90M | $-31.64M | $-25.62M | $-23.80M | $5.68M | $-22.61M | $-23.29M | $-8.63M | $5.16M | $43.45M | $-39.81M |
| Low Forecast | $-7.43M | $-7.52M | $-7.67M | $-9.09M | $-11.22M | $-11.89M | $-14.04M | $-16.11M | $-19.55M | $-24.41M | $-26.81M | $-42.28M | $-40.12M | $-30.13M | $-31.88M | $-38.43M | $-23.98M | $3.79M | $-26.62M | $-34.94M | $-12.94M | $3.44M | $28.97M | $-59.72M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.01% | 1.34% | 1.24% | 1.14% | 1.17% | -20.04% | - | 0.91% | 1.15% | 1.82% | 1.08% | 1.90% |
Danimer Scientific's average Quarter net income forecast for Dec 21 is $-10.79M, with a range of $-12.94M to $-8.63M. DNMR's average Quarter net income forecast represents a -237.85% decrease compared to the company's last Quarter net income of $7.83M (Sep 21).
Danimer Scientific SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - | - | - | 1 | - | 1 | 2 | 1 | 1 | 1 | - | - | - | - | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $16.89M | $16.55M | $16.84M | $18.70M | $19.55M | $19.41M | - | $22.24M | $24.21M | $26.59M | $19.08M | $10.12M |
| Avg Forecast | $41.87M | $37.59M | $33.31M | $29.03M | $29.15M | $25.65M | $21.10M | $15.66M | $13.40M | $9.01M | $9.43M | $11.27M | $12.15M | $15.48M | $14.60M | $15.12M | $17.26M | $13.09M | $16.13M | $22.48M | $18.58M | $15.30M | $12.39M | $5.32M |
| High Forecast | $42.01M | $37.72M | $33.43M | $29.13M | $29.25M | $25.74M | $21.18M | $15.72M | $13.45M | $9.04M | $9.47M | $11.31M | $12.19M | $15.54M | $14.65M | $15.17M | $17.32M | $13.14M | $17.14M | $22.65M | $18.72M | $15.41M | $12.49M | $6.38M |
| Low Forecast | $41.77M | $37.50M | $33.23M | $28.96M | $29.08M | $25.59M | $21.05M | $15.62M | $13.37M | $8.99M | $9.41M | $11.24M | $12.12M | $15.45M | $14.56M | $15.08M | $17.22M | $13.06M | $15.12M | $22.22M | $18.37M | $15.12M | $12.25M | $4.25M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.39% | 1.07% | 1.15% | 1.24% | 1.13% | 1.48% | - | 0.99% | 1.30% | 1.74% | 1.54% | 1.90% |
Danimer Scientific's average Quarter SG&A projection for Mar 24 is $11.27M, based on 1 Wall Street analysts, with a range of $11.24M to $11.31M. The forecast indicates a -33.26% fall compared to DNMR last annual SG&A of $16.89M (Dec 23).
Danimer Scientific EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | - | - | - | - | 1 | - | 1 | 2 | 1 | 1 | 1 | - | - | - | - | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.39 | - | $-0.38 | $-0.36 | $-0.28 | $-0.94 | - | $-0.26 | $-0.12 | $0.08 | $1.12 | $-2.10 |
| Avg Forecast | $-0.06 | $-0.06 | $-0.07 | $-0.08 | $-0.10 | $-0.10 | $-0.12 | $-0.14 | $-0.17 | $-0.20 | $-0.23 | $-0.28 | $-0.34 | $-0.26 | $-0.27 | $-0.29 | $-0.20 | $-0.21 | $-0.24 | $-0.20 | $-0.15 | $-0.08 | $-0.07 | $-0.06 |
| High Forecast | $-0.06 | $-0.06 | $-0.07 | $-0.08 | $-0.10 | $-0.10 | $-0.12 | $-0.14 | $-0.17 | $-0.19 | $-0.23 | $-0.28 | $-0.32 | $-0.26 | $-0.27 | $-0.29 | $-0.20 | $-0.21 | $-0.22 | $-0.20 | $-0.15 | $-0.08 | $-0.07 | $-0.06 |
| Low Forecast | $-0.06 | $-0.06 | $-0.07 | $-0.08 | $-0.10 | $-0.10 | $-0.12 | $-0.14 | $-0.17 | $-0.21 | $-0.23 | $-0.28 | $-0.34 | $-0.26 | $-0.27 | $-0.29 | $-0.21 | $-0.21 | $-0.26 | $-0.21 | $-0.15 | $-0.08 | $-0.07 | $-0.06 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.16% | - | 1.39% | 1.24% | 1.37% | 4.53% | - | 1.27% | 0.80% | -1.04% | -16.00% | 35.00% |
According to 1 Wall Street analysts, Danimer Scientific's projected average Quarter EPS for Dec 21 is $-0.15, with a low estimate of $-0.15 and a high estimate of $-0.15. This represents a -287.50% decrease compared to DNMR previous annual EPS of $0.08 (Sep 21).
Danimer Scientific Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ALTO | Alto Ingredients | $1.54 | $3.50 | 127.27% | Buy |
| DNMR | Danimer Scientific | $0.40 | $0.90 | 125.00% | Hold |
| OEC | Orion Engineered Carbons | $16.91 | $32.00 | 89.24% | Buy |
| LTHM | Livent | $16.51 | $27.33 | 65.54% | Buy |
| ECVT | Ecovyst | $6.68 | $10.00 | 49.70% | Buy |
| OLN | Olin | $42.96 | $62.23 | 44.86% | Buy |
| MTX | Minerals | $72.81 | $90.00 | 23.61% | Buy |
| KWR | Quaker Chemical | $164.69 | $197.50 | 19.92% | Buy |
| SQM | Sociedad Química y Minera de Chile | $38.23 | $45.75 | 19.67% | Buy |
| DD | DuPont de Nemours | $81.42 | $93.29 | 14.58% | Buy |
| WLK | Westlake | $138.93 | $158.64 | 14.19% | Hold |
| LYB | LyondellBasell Industries | $93.18 | $102.47 | 9.97% | Buy |
| EMN | Eastman Chemical Company | $103.10 | $110.41 | 7.09% | Buy |
| APD | Air Products and Chemicals | $284.13 | $300.08 | 5.61% | Hold |
| IFF | International Flavors & Fragrances | $103.59 | $108.23 | 4.48% | Buy |
| CBT | Cabot | $104.75 | $99.50 | -5.01% | Hold |
| KRO | Kronos Worldwide | $11.22 | $9.00 | -19.79% | Sell |
DNMR Forecast FAQ
Is Danimer Scientific a good buy?
No, according to 3 Wall Street analysts, Danimer Scientific (DNMR) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 0 'Buy' recommendations, accounting for 0% of DNMR's total ratings.
What is DNMR's price target?
Danimer Scientific (DNMR) average price target is $0.9 with a range of $0.8 to $1, implying a 127.85% from its last price of $0.395. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Danimer Scientific stock go up soon?
According to Wall Street analysts' prediction for DNMR stock, the company can go up by 127.85% (from the last price of $0.395 to the average price target of $0.9), up by 153.16% based on the highest stock price target, and up by 102.53% based on the lowest stock price target.
Can Danimer Scientific stock reach $1?
DNMR's average twelve months analyst stock price target of $0.9 does not support the claim that Danimer Scientific can reach $1 in the near future.
What is Danimer Scientific's current price target trend?
1 Wall Street analyst forecast a $1 price target for Danimer Scientific (DNMR) this month, up 153.16% from its last price of $0.395. Compared to the last 3 and 12 months, the average price target increased by 153.16% and increased by 158.23%, respectively.
What are Danimer Scientific's analysts' financial forecasts?
Danimer Scientific's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $87.18M (high $87.48M, low $86.98M), average EBITDA is $-56.711M (high $-56.579M, low $-56.91M), average net income is $-53.022M (high $-52.861M, low $-53.264M), average SG&A $91.56M (high $91.88M, low $91.35M), and average EPS is $-0.455 (high $-0.454, low $-0.457). DNMR's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $135.01M (high $135.48M, low $134.7M), average EBITDA is $-87.827M (high $-87.622M, low $-88.134M), average net income is $-31.574M (high $-31.478M, low $-31.717M), average SG&A $141.79M (high $142.29M, low $141.46M), and average EPS is $-0.271 (high $-0.27, low $-0.272).
Did the DNMR's actual financial results beat the analysts' financial forecasts?
Based on Danimer Scientific's last annual report (Dec 2023), the company's revenue was $46.68M, which missed the average analysts forecast of $54.6M by -14.51%. Apple's EBITDA was $-126M, beating the average prediction of $-54.665M by 129.80%. The company's net income was $-155M, beating the average estimation of $-133M by 17.01%. Apple's SG&A was $68.98M, beating the average forecast of $57.35M by 20.29%. Lastly, the company's EPS was $-1.52, beating the average prediction of $-1.156 by 31.50%. In terms of the last quarterly report (Dec 2023), Danimer Scientific's revenue was $10.94M, missing the average analysts' forecast of $11.57M by -5.39%. The company's EBITDA was $-31.032M, beating the average prediction of $-7.526M by 312.35%. Danimer Scientific's net income was $-39.434M, beating the average estimation of $-39.117M by 0.81%. The company's SG&A was $16.88M, beating the average forecast of $12.15M by 38.97%. Lastly, the company's EPS was $-0.39, beating the average prediction of $-0.336 by 16.12%